20
Aurobindo Pharma Limited Hyderabad In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Fluoxetine hydrochloride, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2006-131 - Rev 02
This Chemical Type CEP, issued on December 19, 2017, remains in force until January 26, 2021, ensuring its reliability within the pharmaceutical industry.
Substance Number 1104 associated with this CEP further emphasizes